In the Media – “Breathing Easy”

Professor Alastair Stewart, Director of the Centre for Personalised Therapeutics Technologies (CPTT) has been featured on Pursuit, the University of Melbourne’s content platform.

The article, breathing easy, highlights research conducted in the Stewart lab on the molecular cause of steroid resistance in the lungs and how this critical problem for severe asthmatics now has a new inhaled treatment on the way…

PhD Scholarship Opportunities

PhD Opportunities with the ARC Centre for Personalised Therapeutics Technologies

We are currently seeking outstanding applicants for multiple PhD scholarship opportunities associated with ARC Centre for Personalised Therapeutics Technologies in the Department of Pharmacology and Therapeutics at The University of Melbourne.

The ARC Industry Transformation Training Centre is a 5-year National/International collaboration with nodes at Monash University and University of Western Australia. The Centre has 15 Industry based partners, is strongly aligned to the goals of industry growth sector body, MTPConnect, and collaborates with Accelerate Australia in experiential entrepreneurship training and mentorship.

The Centre aims to develop breakthrough enabling technology for new industrial applications of organ-on-a-chip technology, including the use of 3D bioprinting technologies across three themes: PhD students will research the use and development of microfluidics environments; real-time cell/organoid assay technologies, and/or bioprinting to generate novel tools for lead qualification in therapeutic discovery. The selected PhD candidates will be co-supervised by Industry and University based supervisors (Prof Alastair Stewart / A/Prof Alice Pebay) and will participate in an entrepreneurship-focussed training programme running in parallel to the PhD research. This programme will cover intellectual property, project management, regulatory environments, innovation, funding models and will include access to highly qualified industry-based mentors.

A tax-free scholarship of AU$31,828 is available to successful candidates for 3 years, with potential for a single extension of 6-months. It is a condition of the scholarship that the successful applicant completes a minimum of 12-month placement with an ARC CPTT industry partner during and as part of their candidature.  Selected applicants may be eligible and encouraged to apply for alternative competitive scholarships.

Applicants must meet the eligibility criteria for enrolment in Doctor of Philosophy (PhD), including the required level of English language proficiency.  In addition, a high level of interpersonal skill level is required for this demanding and highly privileged opportunity.

Expressions of interest are invited from applicants with an appropriate background, until the end of 2018 (or until filled).

Selection Criteria

  • Academic merit and CV;
  • Area of study and research proposal;
  • Academic referee reports;
  • Interest in and/or experience working with industry partners;
  • Evidence of well-developed interpersonal and written communication skills.

For more information please contact Centre Manager, Dr Narelle Tunstall narelle.tunstall@unimelb.edu.au

The ARC CPTT is funded by the Australian Government through the ARC Industrial Transformation Research Program.

Training Opportunity – MedTech Actuator

The Medtech Actuator is offering training programs that are designed for aspiring entrepreneurs to explore opportunities in medtech commercialisation and to receive the necessary skills and knowledge to kickstart their commercialisation journey.

The Medtech Actuator is looking to run a class in August.  Tailored Masterclasses are for a group of ~20 individuals.

Aspiring entrepreneurs from the University of Melbourne:
If you are interested in attending, please fill the attached Training Program Form. Once you press the ‘Submit Form’ button, the form will be directed to kaushalya@medtechactuator.com.  Please also let Jia-Yee Lee know that you have submitted the form.

The form should be sent preferably by Tuesday 26 June 2018.

Special Meeting – SCDMDD 2018

Stem Cells in Disease Modelling and Drug Discovery (SCDMDD) is a satellite meeting being held in Melbourne June 17-18 ahead of the International Society for Stem Cell Research annual conference 2018.

Our Centre’s Senior ECR Mentor, Associate Professor Alice Pebay will be speaking at this specialised meeting alongside various high profile national and international speakers including LORENZ STUDER from the Memorial Sloan Kettering Cancer Center.

See the full list of speakers and how to register here:
STEM CELLS IN DISEASE MODELLING AND DRUG DISCOVERY
MELBOURNE AUSTRALIA – JUNE 17-18 2018

New Publication – Australasian Biotechnology

THE SOCIAL INVESTMENT OF EARLY-STAGE BIOMEDICAL INNOVATION

Associate Professor Kevin Pfleger, our Deputy Director Entrepreneurship & UWA Node Leader, has published an article in the April Edition of Australasian Biotechnology, AusBiotech‘s official journal, reporting on research and business news within the biotechnology arena.

Associate Professor Pfleger says;

As individuals and institutions, we are passionate about improving people’s health and wellbeing. Why, then, is it so hard to bridge the gap between the world-leading academic research that is so highly regarded by international peers, and tangible benefits for patients?”

See page 72 of the journal to find out his views on how we can better bridge this gap.

 

International Award for CI Megan Munsie

The ARC CPTT is pleased to announce that one of our Chief Investigators,  Associate Professor Megan Munsie, was awarded a prestigious international award for her service to the stem cell community in ethics, engagement, policy and community service.

The International Society for Stem Cell Research (ISSCR) has just announced this year’s recipient of the ISSCR Public Service Award for 2018. The ISSCR has said “Dr. Munsie is a stem cell scientist who has made a significant contribution for many years in outreach to the public and advocacy to policy makers around issues associated with stem cell science and its translation to the clinic.”

The award will be presented to Megan in Plenary II of the ISSCR meeting on Wednesday 20 June, 16:00-18:00.

A/ Prof Megan Munsie is the Head of Education, Ethics, Law & Community Awareness Unit, Stem Cells Australia and Deputy Director at the Centre for Stem Cell Systems, The University of Melbourne. She will be involved with a number of the ARC CPTT research projects run though the University of Melbourne node.

Manager appointed to the ARC CPTT

Dr Narelle Tunstall was recently appointed Manager of the ARC Centre for Personalised Therapeutics Technologies.

Narelle is passionate about supporting researchers, their projects and ultimately research outcomes. After completing a PhD in genetics at Monash University in 2007, Narelle started a postdoctoral position at the Queensland Brain Institute (University of Queensland) before realising the value of her skills in research operations, development and engagement.

Narelle’s research management experience now extends across five Australian Universities including three Group of Eight Universities. She has managed complex research projects including an NHMRC Centre for Clinical Research Excellence and a Commonwealth funded Collaborative Research Network but has also worked in a large, fast-paced Go8 research office during major grant rounds and has completed hundreds of grant reviews (critical review, eligibility and compliance). Most recently, she has been Manager of Researcher Development, where she has developed training programs for Graduate and Early Career Researchers.

Narelle is an avid contributor to her profession having previously co-founded the UQ Research Administrators Network and is currently Treasurer for the Victorian Chapter of the Australasian Research Managers Society (ARMS). In her spare time, she runs a small consultancy focusing on researcher development and grant writing www.empiricalresearch.com.au.